Lamda Partners, a UK private equity house, has invested €90.2m in pharmaceuticals firm Alapis through the purchase of 20 per cent of new ordinary shares.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.